Nasdaq Welcomes Zai Lab Ltd. (Nasdaq: ZLAB) to The Nasdaq

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
532
Nasdaq Welcomes Zai Lab Ltd. (Nasdaq: ZLAB) to The Nasdaq Stock Market

NEW YORK, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Zai Lab Ltd. (Nasdaq: ZLAB ), a biopharmaceutical company based in Shanghai focused on bringing transformative medicines to patients in China and around the world, rang the opening bell at the Nasdaq MarketSite in Times Square today in celebration of its initial public offering (IPO) on The Nasdaq Stock Market.

Photos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/Attachm...f5af48e496

http://www.globenewswire.com/NewsRoom/Attachm...c3db428fd4

Zai Lab focuses on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the areas of oncology, autoimmune and infectious diseases. The company aims to foster innovation by addressing these unmet needs and leveraging underutilized resources in China. Since their founding in 2014, they have assembled an innovative pipeline consisting of six drug candidates through partnerships with global biopharmaceutical companies. In the long term, they plan to build a premier, fully integrated drug discovery and development platform that brings both in-licensed and internally-discovered medicines to patients in China and globally.

“Zai Lab has an extensive track record of developing innovative drugs in China,” said Nelson Griggs, President of the Nasdaq Stock Exchange. “They are able to leverage their resources and expertise in order to meet the expanding needs of the biopharmaceutical industry. We are extremely proud to be their partner throughout their journey as they transform human health services worldwide.”

The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Information about the company is provided by the company or comes from the company’s public filings and is not independently verified by Nasdaq.  Neither Nasdaq nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

About Nasdaq Nasdaq (Nasdaq: NDAQ ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $12 trillion. To learn more, visit:  http://business.nasdaq.com

About Zai Lab Zai Lab (NASDAQ: ZLAB ) is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. The company’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast growing segments of China’s pharmaceutical market and global unmet medical needs. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partner’s and its own products in order to impact human health worldwide.

For more information, please visit www.zailaboratory.com

Media Relations Contacts: Stephanie Lowenthal (646) 441-5073 Stephanie.Lowenthal@nasdaq.com

Emily Pan (646) 441-5120 emily.pan@nasdaq.com

- NDAQG -

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 6

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading
Orthopedic Expert Highlighting Midwest Pain Access Gaps

Updated Category News Views 5

Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...

Continue Reading
FC2 Condom Educates NYC on Health and Wellness

Updated Category News Views 9

Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...

Continue Reading
CSS Revamps Identity, Emphasizing Senior Living Tech

Updated Category News Views 5

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Continue Reading
Mutare Sharpens Security for Webex Calls with Precision

Updated Category News Views 5

Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...

Continue Reading
NY Sheriffs' Court Battle: Immigration Policies Under Fire

Updated Category News Views 5

Sheriffs Clash with State Over Immigration Policies In a tense showdown reminiscent of an old-time standoff, 15 New York county sheriffs have drawn their battle lines against the state’s capricious maneuvers by pushing a federal court to hit the brakes on Albany’s newly minted immigration rule. The so-called “Local Cops, Local Crimes Act” is catching serious heat,...

Continue Reading
Robotics in Cleaning: 2026 Sees Double Adoption Rates

Updated Category News Views 4

Cleaning Industry Eyes Robotic Solutions Amid Labor Squeeze In a twist that's got industry veterans nodding knowingly, the cleaning industry is tipping towards automation. The recent 2026 Building Service Contractor Market Study reveals a massive leap: 32% of building service contractors (BSCs) plan to embrace robotic floor equipment in the coming year. That's a...

Continue Reading
WellLink Advisory Board Eyes Future of Healthcare Innovation

Updated Category News Views 3

Strategic Collaboration for Healthcare Evolution Ready to shake things up in healthcare, WellLink is setting the stage with its brand new Advisory Board. This move isn’t just about having fancy titles sitting around a conference table — it's about grabbing onto the future with both hands and figuring out just what the heck the healthcare industry needs next....

Continue Reading
TGI Fridays Unveils New 3 For All Menu Options

Updated Category News Views 8

Hedging Bets on New Dining Strategies Oh, the restaurant battlefield—where one day you're the toast of the town, and the next, you're hustling to keep those seats filled. TGI Fridays, a name as synonymous with casual eats as long as I’ve been in this game, is rolling the dice with a new offering dubbed '3 For All.' Doesn't sound like your average meal deal either....

Continue Reading
Rosewood HK Tops Best Hotel List Again; Asia Shines

Updated Category News Views 3

Holding the Crown: Rosewood Hong Kong's Triumph When a single hotel keeps nabbing the top spot in the world's most prestigious rankings, it's worth taking a closer look. That's exactly what's happening with Rosewood Hong Kong, crowned the world's best once more in 2026—its second consecutive year at the pinnacle according to The 50 Best Hotels. Defining Luxury on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Humana's Decreased Short Interest and Market Impact

Updated Category News Views 102

Understanding Humana's Short Interest Trends Recently, Humana Inc (NYSE: HUM) has reported a notable decline in its short percent of float, decreasing by 6.3% since the previous report. As of now, the company has approximately 4.30 million shares sold short, which constitutes about 3.57% of the total shares available for trading. Based on the current trading volumes, it...

Continue Reading
Enphase Energy Faces Selling Pressure Amid Solar Stock Decline

Updated Category News Views 190

Enphase Energy's Recent Performance Enphase Energy Inc (NASDAQ: ENPH) has seen its shares decline sharply following the release of its quarterly results. Despite posting better than expected financial numbers, the outlook for the coming quarter has disappointed analysts. Quarterly Results Analysis In the latest quarter, Enphase Energy surprised with revenues of $363.15...

Continue Reading
Empowering Lives: Aventiv Technologies' Impact on Reentry Success

Updated Category News Views 500

Aventiv Technologies: Championing Reentry and Economic Growth Company's Fair Chance Hiring Model Exceeds Goals, While Technology Platforms Connect Incarcerated Individuals with Critical Reentry Resources Aventiv Technologies is making strides in promoting economic growth by supporting the successful reentry of incarcerated individuals. As a pioneering force in...

Continue Reading
Projected Growth of Cancer Antibody Drug Conjugates Market

Updated Category News Views 39

Understanding the Cancer Antibody Drug Conjugates Market The global landscape of cancer treatment is undergoing a transformative phase, significantly influenced by the advancement of cancer antibody drug conjugates (ADCs). These innovative therapies combine the potent cytotoxic effects of traditional chemotherapy with the targeted action of monoclonal antibodies, leading...

Continue Reading
NVIDIA's Anticipated Earnings Report: Key Insights for Investors

Updated Category News Views 145

Understanding NVIDIA's Upcoming Earnings Announcement NVIDIA (NASDAQ: NVDA) is set to release its much-anticipated quarterly earnings report soon. Investors are keen to understand how the company is performing and what guidance it will provide for future quarters. Analysts predict that NVIDIA will announce an earnings per share (EPS) of $0.98, which indicates the level of...

Continue Reading